Cite
Memarpour S, Khalili-Tanha G, Ghannad AA, et al. The Clinical Application of Circulating Tumor Cells and DNAs as Prognostic and Predictive Biomarkers in Gastrointestinal Cancer. Curr Cancer Drug Targets. 2021;21(8):676-688doi: 10.2174/1568009621666210311090531.
Memarpour, S., Khalili-Tanha, G., Ghannad, A. A., Razavi, M. S., Joudi, M., Joodi, M., Ferns, G. A., Hassanian, S. M., Khazaei, M., & Avan, A. (2021). The Clinical Application of Circulating Tumor Cells and DNAs as Prognostic and Predictive Biomarkers in Gastrointestinal Cancer. Current cancer drug targets, 21(8), 676-688. https://doi.org/10.2174/1568009621666210311090531
Memarpour, Sara, et al. "The Clinical Application of Circulating Tumor Cells and DNAs as Prognostic and Predictive Biomarkers in Gastrointestinal Cancer." Current cancer drug targets vol. 21,8 (2021): 676-688. doi: https://doi.org/10.2174/1568009621666210311090531
Memarpour S, Khalili-Tanha G, Ghannad AA, Razavi MS, Joudi M, Joodi M, Ferns GA, Hassanian SM, Khazaei M, Avan A. The Clinical Application of Circulating Tumor Cells and DNAs as Prognostic and Predictive Biomarkers in Gastrointestinal Cancer. Curr Cancer Drug Targets. 2021;21(8):676-688. doi: 10.2174/1568009621666210311090531. PMID: 33719973.
Copy
Download .nbib